Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Why Amarin Is Struggling So Much
Seeking Alpha
Tuesday, March 26, 2013 - 10:16am
tags:
Amarin, GSK
Otsuka to Pay Lundbeck $825 Million for Alzheimer’s Drug
Bloomberg
Tuesday, March 26, 2013 - 10:15am
tags:
Otsuka, Alzheimer's disease, Lu AE58054
Aubagio EU Backing Comes With Generic Worries
Seeking Alpha
Tuesday, March 26, 2013 - 9:33am
tags:
Aubagio, Europe, generics, Sanofi, MS, multiple sclerosis
Eli Lilly Submits New Type 2 Diabetes Drug for FDA Review
Motley Fool
Tuesday, March 26, 2013 - 9:20am
tags:
diabetes, FDA, Eli Lilly, Boehringer Ingelheim, empagliflozin
J&J recalling more than 2 mln blood glucose meters worldwide
Reuters
Monday, March 25, 2013 - 12:17pm
tags:
JNJ, LifeScan, recalls, blood glucose monitoring
Obagi Medical Sued by Investor Over $360 Million Offer
Bloomberg
Monday, March 25, 2013 - 12:16pm
tags:
Obagi Medical Products, M&A, Valeant Pharmaceuticals
BioMarin: Gains To Continue As Pipeline Progress Is Realized
Seeking Alpha
Monday, March 25, 2013 - 12:15pm
tags:
Biomarin
Cytokinetics: Critical Phase IIb Data Is Upcoming In 2013 For Omecamtiv Mecarbil And Tirasemtiv
Seeking Alpha
Monday, March 25, 2013 - 12:06pm
tags:
Cytokinetics, Omecamtiv Mecarbil, Tirasemtiv
Idenix Loses First Phase Of Patent Dispute With Gilead Sciences
TheStreet.com
Monday, March 25, 2013 - 12:05pm
tags:
Gilead, Idenix, patents, hepatitis C, sofosbuvir
Vanda reports successful completion of pre-NDA meeting with FDA on tasimelteon
Yahoo/Fly on the Wall
Monday, March 25, 2013 - 11:11am
tags:
FDA, tasimelteon, Vanda, non-24 hour disorder
Sarepta set to rise if seeks quick drug OK
Reuters
Monday, March 25, 2013 - 11:09am
tags:
Sarepta, eteplirsen, Duchenne Muscular Dystrophy
Theravance Seen Luring Glaxo Bid as Drugs Near FDA Nod: Real M&A
Bloomberg
Monday, March 25, 2013 - 11:07am
tags:
GSK, Theravance, M&A
FDA Denies Approval For Glaxo Bird Flu Vaccine
Pharmalot
Monday, March 25, 2013 - 11:06am
tags:
FDA, GSK, bird flu, vaccines, Q-Pan H5N1
Sanofi to Seek More Venture-Capital Deals
Bloomberg
Monday, March 25, 2013 - 11:05am
tags:
Sanofi, venture capital, Warp Drive Bio
FDA rejects United Therapeutics' oral hypertension drug again
Reuters
Monday, March 25, 2013 - 11:03am
tags:
antihypertensives, FDA, United Therapeutics, Treprostinil
Drug Companies Have Rebounded From The Patent Cliff With Acquisitions Now On The Mind
Seeking Alpha
Monday, March 25, 2013 - 11:00am
tags:
patent cliff, M&A, Teva, Pfizer, Novartis, GSK, Dendreon, AstraZeneca, Advaxis
Pfizer says XELJANZ approved in Japan for treatment of adults with RA
Yahoo/Fly on the Wall
Monday, March 25, 2013 - 10:59am
tags:
Pfizer, Xeljanz, rheumatoid arthritis, Japan
Actavis reaches agreement with AstraZeneca to launch generic Crestor in 2016
Yahoo/Fly on the Wall
Monday, March 25, 2013 - 10:57am
tags:
generics, Crestor, Actavis, AstraZeneca
Supreme Court: Can drug companies pay to delay generics?
Yahoo/AP
Monday, March 25, 2013 - 10:57am
tags:
pay-for-delay, generics, Supreme Court
2 Can't-Miss FDA Rulings Next Week
Motley Fool
Sunday, March 24, 2013 - 12:27pm
tags:
JNJ, Invokana, type 2 diabetes, diabetes, pulmonary arterial hypertension, Treprostinil

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.